Table 3 Comparison of clinical and laboratory parameters at T0 and T6 in 41 RA patients
From: Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis
Variables | T0 | T6 | p |
|---|---|---|---|
Clinical parameters | |||
DAS28 | 4.46 (1.15) (2.58–6.55) | 3.33 (1.62) (0.66–6.88) | < 0.001 |
M-HAQ | 1.22 (0.52) (0–2.38) | 1.31 (0.52) (0.25–2.38) | NS |
SBP, mmHg | 123.8 (13.5) (90–160) | 128.2 (13.6) (105–160) | NS |
BMI, kg/m2 | 24.8 (3.1) (18.6–29.95) | 25.9 (3.4) (17.3–33.2) | 0.002 |
BMI > 30 kg/m2 | 0 | 5 (12.2) | 0.03 |
mSCORE, % | 0.98 (2.1) (0–12) | 2.99 (3.9) (0–18) | < 0.001 |
High/very high CVD risk | 2 (4.9) | 10 (24.4) | 0.01 |
QTc, ms | 341.9 (60.8) (187–446) | 358.8 (59.5) (175–453) | NS |
cIMT, mm | 0.76 (0.15) (0.43–1.2) | 0.87 (0.21) (0.57–1.77) | < 0.001 |
Carotid plaques presence | 6 (14.6) | 10 (24.4) | NS |
Laboratory parameters | |||
NT-proBNP, pg/ml | 88.9 (78) (12.2–351.2) | 126.6 (186.5) (20.1–1175) | NS |
Glucose, mg/dl | 89.3 (12.9) (54–120) | 88.8 (14.5) (67–146) | NS |
TC, mg/dl | 200.6 (42) (135–325) | 206.3 (7.2) (101–318) | NS |
HDL-C, mg/dl | 59.6 (14.2) (39–87) | 60.3 (16.2) (30–102) | NS |
LDL-C, mg/dl | 119.7 (36.2) (47–232) | 120.8 (34.4) (41–190) | NS |
Triglycerides, mg/dl | 106.5 (45.6) (43–214) | 113.0 (53.5) (23–251) | NS |
AI (TC/HDL-C) | 3.48 (0.81) (2.1–5.5) | 3.53 (0.84) (2.0–5.8) | NS |
Serum creatinine, mg/dl | 0.68 (0.15) (0.4–1.0) | 0.66 (0.15) (0.4–1.0) | NS |
Serum uric acid, mg/dl | 4.0 (0.9) (2.2–5.8) | 4.5 (1.1) (2.5–7) | < 0.05 |